Skip to main content
. Author manuscript; available in PMC: 2011 Aug 30.
Published in final edited form as: Int J Pharm. 2010 Jul 1;396(1-2):111–118. doi: 10.1016/j.ijpharm.2010.06.039

Fig. 2.

Fig. 2

Concentration-dependent uptake of CDCA-lysine-niacin (A) and CDCA-lysine-ketoprofen (B) into ASBT-MDCK monolayers for 10 min. The conjugate was measured at varying concentrations in the presence and absence of sodium to delineate ASBT-mediated and passive uptake components. Data indicate total uptake in the presence of sodium (●) and passive uptake in the absence of sodium (○), while the solid line indicates model fit of the total uptake.